key: cord-0891952-3wjmmz1g
authors: Kahlberg, Andrea; Mascia, Daniele; Bellosta, Raffaello; Attisani, Luca; Pegorer, Matteo; Socrate, Anna Maria; Ferraris, Matteo; Trabattoni, Piero; Rinaldi, Enrico; Melloni, Andrea; Monaco, Fabrizio; Melissano, Germano; Chiesa, Roberto
title: Vascular Surgery during COVID-19 Emergency in Hub Hospitals of Lombardy: Experience on 305 Patients
date: 2020-11-13
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2020.10.025
sha: fbefcc0ddea642975531b90b79a60edca06b6025
doc_id: 891952
cord_uid: 3wjmmz1g

Objective During the most aggressive phase of the COVID-19 outbreak in Italy, the Regional Authority of Lombardy identified a number of hospitals, named Hubs, chosen to serve the whole region for highly specialised cases, including vascular surgery. This study reports the experience of the four Hubs for Vascular Surgery in Lombardy and provides a comparison of in hospital mortality and major adverse events (MAEs) according to COVID-19 testing. Methods Data from all patients who were referred to the Vascular Surgery Department of Hubs from 9 March to 28 April 2020 were collected prospectively and analysed. A positive COVID-19 polymerase chain reaction swab test, or symptoms (fever > 37.5°C, upper respiratory tract symptoms, chest pain, and contact/travel history) associated with interstitial pneumonia on chest computed tomography scan were considered diagnostic of COVID-19 disease. Patient characteristics, operative variables, and in hospital outcomes were compared according to COVID-19 testing. A multivariable model was used to identify independent predictors of in hospital death and MAEs. Results Among 305 included patients, 64 (21%) tested positive for COVID-19 (COVID group) and 241 (79%) did not (non-COVID group). COVID patients presented more frequently with acute limb ischaemia than non-COVID patients (64% vs. 23%; p < .001) and had a significantly higher in hospital mortality (25% vs. 6%; p < .001). Clinical success, MAEs, re-interventions, and pulmonary and renal complications were significantly worse in COVID patients. Independent risk factors for in hospital death were COVID (OR 4.1), medical treatment (OR 7.2), and emergency setting (OR 13.6). COVID (OR 3.4), obesity class V (OR 13.5), and emergency setting (OR 4.0) were independent risk factors for development of MAEs. Conclusion During the COVID-19 pandemic in Lombardy, acute limb ischaemia was the most frequent vascular disease requiring surgical treatment. COVID-19 was associated with a fourfold increased risk of death and a threefold increased risk of major adverse events.

clinical success was defined as clinical success with/without the need for an additional 145 or secondary surgical or endovascular procedure, respectively. 146

Post-operative complications were defined according to the SVS reporting 147 standards. 9 A peri-operative complication was referred as MAE when graded > 1, or 148 in case of secondary major amputation. 149

Categorical variables were expressed as frequencies and percentages. Continuous 151 variables were tested for normal distribution using the Kolmogorov-Smirnov test; 152 those with normal distribution were expressed as mean and standard deviation, those 153

with non-normal distribution as median and interquartile range. 154

Patients were divided in two groups according to COVID-19 testing: the 155 COVID group patients who tested positive on admission or during hospitalisation, and 156 the non-COVID group patients who always tested negative. Differences between 157 groups were tested using the Fisher exact test for dichotomous variables, and the 158 Student t test or the Mann-Whitney test for continuous variables, as appropriate. All 159 tests were two tailed, and p ≤ .05 was considered to be statistically significant. 24.6% and mean measured arterial partial pressure of oxygen (PaO 2 ) was 80.0 mmHg 179 ± 36.2 mmHg. 180

Demographics and pre-operative risk factors are summarised in Table 2 Table 3 . 219

Overall, 21 patients (6.9%) were treated medically, and 284 (93.1%) surgically 220 (Table 3) . Reasons for choosing medical therapy alone were high surgical risk, related 221 to SARS-CoV-2 infection in seven patients and to general comorbidities or advanced 222 age in six; vascular disease severity too low to justify urgent intervention in six 223 patients; and patient refusal in two cases. COVID patients underwent medical 224 treatment alone more frequently than non-COVID patients (14.1% vs. 5.0%; 225 p = .022), whereas the latter underwent endovascular interventions more frequently 226 than the former (26.6% vs. 9.4%; p = .003). 227

Global in hospital mortality was 10.2% (31 patients), and was higher in 228 patients treated medically (38.1% vs. 8.1%; p < .001). 229

Cause of death was multi-organ failure in 10 cases (five COVID), respiratory 230 failure in nine (all COVID patients), cardiac failure in four (one COVID), aortic 231 rupture in two (both non-COVID patients treated medically for general 232 comorbidities), cerebral ischaemia in two (both non-COVID), sepsis in one (non-233 COVID), and aortic thrombosis with bowel ischaemia in one case (COVID). In two 234 non-COVID patients the cause of death was unknown. 235

Patients with COVID had a significantly higher mortality (25.0% vs. 6.2%; 236 p < .001). When stratified by type of vascular disease, type of intervention, and timing 237 (Table 4 ), in hospital mortality was significantly higher in COVID patients, especially 238 in cases of ALI or CLTI, in open surgical intervention cases, and in the elective 239

Operative details and in hospital outcomes of patients submitted to surgical 241 interventions are reported in Table 5 . Only one patient, an 85 year old man with a 242 was 15.2% (14/92) for ALI, 3.2% (2/63) for CLTI, 6.9% (2/29) for limb 244 necrosis/gangrene, 9.8% (4/41) for aortic disease, and 2.9% (1/35) for cerebrovascular 245 disease. Peri-operative pulmonary (grades 2 and 3) and renal (grade 2) complications 246 occurred more frequently in COVID patients (Table 5) . 247

On multivariable analysis of predictive factors for in hospital death and MAEs 248 (Table 6) , COVID, medical treatment, and emergency setting were independently 249 associated with the risk of in hospital death, with an OR of 4.1, 7.2, and 13.6, 250

respectively. COVID, obesity class V, and emergency setting were independently 251 associated with the risk of MAEs, with an OR of 3.4, 13.5, and 4.0, respectively. 252

Rapid spread of the COVID-19 pandemic imposed a need to find a model to 254 guarantee the treatment of positive patients in tertiary hospitals, but maintaining 255 standard quality of treatment for other pathologies. 10,11 How regional authorities in 256

Lombardy decided to create the cardiovascular Hub/Spoke system that would serve 257 the whole region for non-elective and elective cases has been reported previosly. 12 258 first reported the increase in the incidence and extension of native peripheral arterial 268 occlusion in COVID-19 patients. 269

The results are consistent with those previously published; in particular, it was 270 found that COVID patients presenting with ALI had the highest peri-operative 271 mortality, even higher than patients presenting with aortic disease in the same time (Table 5) . 292

In the exceptional conditions in which patients have been evaluated, 293

identifying which vascular patients should be included or excluded from urgent care 294 (Table 1) is both difficult and dangerous, but a regional consensus about indications 295 for hospital admission and treatment was obtained. Further international discussion is 296 needed about these criteria, and about safe protocols that may guarantee COVID free 297 hospital access to the vascular patient. 298

A large number of patients who presented with vascular diseases associated 299 with COVID-19 pulmonary and/or systemic complications were considered unfit for 300 surgery, and medical therapy was indicated due to poor general condition (14% of the 301 cohort). Moreover, among patients undergoing medical therapy, an in hospital 302 mortality of 55% was recorded, the highest recorded in the subgroups of this study. 303

This finding was confirmed on multivariable analysis, in which medical therapy was 304 associated with a sevenfold increased risk of death. 305

In this view, the recent ESVS guidelines on the management of ALI, 21 306 published in January 2020, just before the pandemic outbreak, stated that ALI often 307 affects very frail patients and that decision making between surgical and medical 308 approaches may be difficult. In particular, in patients suffering from associated 309 threatening diseases (such as full blown COVID-19) thrombosis may be a terminal 310 event, sometimes being referred to as agonal thrombosis. These considerations adapt 311 well in the particular, dramatic situation that occurred during the COVID-19 312 emergency, and probably underlie the high number of patients treated conservatively, 313

and who are dead as a consequence. B). If in normal times this seems to be adequate, during the COVID-19 outbreak CT 317 scanners were extremely busy screening patients for pneumonia, so probably other 318 diagnostic modalities (e.g., Doppler ultrasound and digital subtraction angiography) 319 should be preferred. Interestingly, it was also found that the delay from the onset of 320 symptoms to definitive treatment was significantly higher in COVID-19 patients. A isolated from the community and labelled as "suspect COVID" rather than given the 363 work up necessary to diagnose vascular graft infection.

mortality, especially in patients selected for medical treatment. COVID-19 was 367 associated with a fourfold increased risk of mortality and a threefold increased risk of 368

MAEs. In the immediate future, international collaborative studies (e.g., the COvid-19 369

Vascular sERvice [COVER] Study initiative 26 ) will be extremely important to assess 370 the changes in practice and the outcomes of vascular surgery during the COVID-19 371 pandemic, and to propose specific therapeutic protocols in these patients. 372

None. 374

None. 376 

Acute limb ischemia in patients with COVID-19 pneumonia

Is it 441 possible to safely maintain a regular vascular practice during the COVID-19 442 pandemic?

Vascular surgery in unreal times

Editor's Choice -European Society for Vascular Surgery (ESVS) 2020 clinical 448 practice guidelines on the management of acute limb ischaemia

Estimation of global and regional incidence and prevalence of abdominal 452 aortic aneurysms 1990 to 2010

Editor's Choice -Trend-break in abdominal 454 range). ICU = intensive care unit

MAE = major adverse event

PTCA = percutaneous transluminal coronary 502 angioplasty

AKIN = Acute Kidney Injury Network grading

* Parametric test (Student t test) was used for comparison

† The patient who died intra-operatively is not considered

‡ Non-parametric test (Mann-Whitney U Test) was used for comparison